Stock Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron Announces Collaboration with Mitsubishi Tanabe Pharma for Investigational Pain Therapy Fasinumab in Asia

[PR Newswire] – Tarrytown, N.Y., Oct. 1, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a collaboration with Mitsubishi Tanabe Pharma Corporation (TSE: 4508) (MTPC) providing MTPC with exclusive development and . . . → Read More: Stock Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron Announces Collaboration with Mitsubishi Tanabe Pharma for Investigational Pain Therapy Fasinumab in Asia Similar Articles: Stock Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron and Sanofi Announce New Positive Praluent® (alirocumab) Phase 3 Data Presented at ESC Congress 2015 Stock Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron Reports Second Quarter 2015 Financial and Operating Results Company Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia